These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23038654)

  • 21. Downbeat positioning nystagmus is a common clinical feature despite variable phenotypes in an FHM1 family.
    Yabe I; Kitagawa M; Suzuki Y; Fujiwara K; Wada T; Tsubuku T; Takeichi N; Sakushima K; Soma H; Tsuji S; Niino M; Saitoh S; Sasaki H
    J Neurol; 2008 Oct; 255(10):1541-4. PubMed ID: 18670797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deconstructing speech alterations in episodic ataxia type 2: Perceptual-acoustic analysis in a case due to CACNA1A gene mutation.
    Argenziano G; Cavallieri F; Monfrini E; Gessani A; Russo M; Rizzi R; Fioravanti V; Grisanti S; Toschi G; Napoli M; Pascarella R; Budriesi C; Di Fonzo A; Zucco R; Valzania F
    Parkinsonism Relat Disord; 2023 Mar; 108():105311. PubMed ID: 36805178
    [No Abstract]   [Full Text] [Related]  

  • 23. Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2.
    Choi KD; Yook JW; Kim MJ; Kim HS; Park YE; Kim JS; Choi JH; Shin JH; Kim DS
    Neurol Sci; 2013 Sep; 34(9):1629-32. PubMed ID: 23344743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy.
    Vahedi K; Denier C; Ducros A; Bousson V; Levy C; Chabriat H; Haguenau M; Tournier-Lasserve E; Bousser MG
    Neurology; 2000 Oct; 55(7):1040-2. PubMed ID: 11061267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms.
    Damaj L; Lupien-Meilleur A; Lortie A; Riou É; Ospina LH; Gagnon L; Vanasse C; Rossignol E
    Eur J Hum Genet; 2015 Nov; 23(11):1505-12. PubMed ID: 25735478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine.
    Strupp M; Kalla R; Dichgans M; Freilinger T; Glasauer S; Brandt T
    Neurology; 2004 May; 62(9):1623-5. PubMed ID: 15136697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dramatically different levels of Cacna1a gene expression between pre-weaning wild type and leaner mice.
    Veneziano L; Albertosi S; Pesci D; Mantuano E; Frontali M; Jodice C
    J Neurol Sci; 2011 Jun; 305(1-2):71-4. PubMed ID: 21440913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel CACNA1A mutation results in episodic ataxia with migrainous features without headache.
    Magis D; Boon E; Coppola G; Daron A; Schoenen J
    Cephalalgia; 2012 Nov; 32(15):1147-9. PubMed ID: 22942164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial episodic ataxia type II.
    Mugundhan K; Thiruvarutchelvan K; Sivakumar S
    J Assoc Physicians India; 2011 Oct; 59():668-70. PubMed ID: 22479753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and genetic characterization of CACNA1A-related disease.
    Lipman AR; Fan X; Shen Y; Chung WK
    Clin Genet; 2022 Oct; 102(4):288-295. PubMed ID: 35722745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study.
    Claassen J; Teufel J; Kalla R; Spiegel R; Strupp M
    J Neurol; 2013 Feb; 260(2):668-9. PubMed ID: 23183922
    [No Abstract]   [Full Text] [Related]  

  • 32. De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia.
    Yue Q; Jen JC; Thwe MM; Nelson SF; Baloh RW
    Am J Med Genet; 1998 May; 77(4):298-301. PubMed ID: 9600739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downbeat nystagmus in two siblings with spinocerebellar ataxia type 6 (SCA 6).
    Harada H; Tamaoka A; Watanabe M; Ishikawa K; Shoji S
    J Neurol Sci; 1998 Oct; 160(2):161-3. PubMed ID: 9849799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult-onset Migraine and Very Late Onset Ataxia Due to a Novel Pathogenic Variant of the CACNA1A Gene.
    Bhattacharjee S; Paramanandam V
    Neurol India; 2023; 71(6):1307-1308. PubMed ID: 38174495
    [No Abstract]   [Full Text] [Related]  

  • 35. Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination.
    Wolf NI; Cundall M; Rutland P; Rosser E; Surtees R; Benton S; Chong WK; Malcolm S; Ebinger F; Bitner-Glindzicz M; Woodward KJ
    Neurogenetics; 2007 Jan; 8(1):39-44. PubMed ID: 16969684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stepwise developmental regression associated with novel CACNA1A mutation.
    Guerin AA; Feigenbaum A; Donner EJ; Yoon G
    Pediatr Neurol; 2008 Nov; 39(5):363-4. PubMed ID: 18940563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A.
    García Segarra N; Gautschi I; Mittaz-Crettol L; Kallay Zetchi C; Al-Qusairi L; Van Bemmelen MX; Maeder P; Bonafé L; Schild L; Roulet-Perez E
    J Neurol Sci; 2014 Jul; 342(1-2):69-78. PubMed ID: 24836863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel CACNA1A mutation associated with adult-onset, paroxysmal head tremor.
    Molloy A; Kimmich O; Martindale J; Moore H; Hutchinson M; O'Riordan S
    Mov Disord; 2013 Jun; 28(6):842-3. PubMed ID: 23696109
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2.
    Mantuano E; Romano S; Veneziano L; Gellera C; Castellotti B; Caimi S; Testa D; Estienne M; Zorzi G; Bugiani M; Rajabally YA; Barcina MJ; Servidei S; Panico A; Frontali M; Mariotti C
    J Neurol Sci; 2010 Apr; 291(1-2):30-6. PubMed ID: 20129625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pearls & Oy-sters: Episodic ataxia type 2: Case report and review of the literature.
    Guterman EL; Yurgionas B; Nelson AB
    Neurology; 2016 Jun; 86(23):e239-41. PubMed ID: 27272039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.